Company intelligence / Profile preview

Personal Cell Sciences

Eatontown, New Jersey, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

PCS commercializes autologous stem cell-based topical skincare products using an individual's own adipose-derived mesenchymal stem cells to create a personalized, growth factor-rich conditioner (Autokine-CM). Clinical trials led by experts in oculoplastic and plastic surgery have reportedly demonstrated efficacy in aesthetics and anti-aging, with the U Autologous product suite named a top beauty breakthrough by major publications[3].

Therapeutic areas: Dermatology
Modalities: Cell therapyStem cell therapyProteinCytokine
Industry: Non-Drug Biotech

Partnerships

American CryoStem Corporation

Beyond the preview

Go deeper on Personal Cell Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Personal Cell Sciences.

Explore the full profile